Publications Repository

Publications Repository

View Item 
  •   Home
  • ICR Divisions
  • Radiotherapy and Imaging
  • View Item
  • Home
  • ICR Divisions
  • Radiotherapy and Imaging
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Imaging and dosimetry for radium-223: the potential for personalized treatment.

Thumbnail
View/Open
Supporting information (63.31Kb)
Publication Date
2017-08
ICR Author
Flux, Glenn
Marsden,
Author
Flux, GD
Type
Journal Article
Metadata
Show full item record
Abstract
Radium-223 (<sup>223</sup>Ra) offers a new option for the treatment of bone metastases from prostate cancer. As cancer treatment progresses towards personalization, the potential for an individualized approach is exemplified in treatments with radiotherapeutics due to the unique ability to image in vivo the uptake and retention of the therapeutic agent. This is unmatched in any other field of medicine. Currently, <sup>223</sup>Ra is administered according to standard fixed administrations, modified according to patient weight. Although gamma emissions comprise only 1% of the total emitted energy, there are increasing reports that quantitative imaging is feasible and can facilitate patient-specific dosimetry. The aim of this article is to review the application of imaging and dosimetry for <sup>223</sup>Ra and to consider the potential for treatment optimization accordingly, in order to ensure clinical and cost effectiveness of this promising agent.
URL
https://repository.icr.ac.uk/handle/internal/1297
Collections
  • Radiotherapy and Imaging
Licenseref URL
https://creativecommons.org/licenses/by-nc/4.0
Version of record
10.1259/bjr.20160748
Subject
Humans
Bone Neoplasms
Prostatic Neoplasms
Radium
Radioisotopes
Radiometry
Male
Precision Medicine
Research team
Radioisotope Physics
Language
eng
License start date
2017-08
Citation
The British journal of radiology, 2017, 90 (1077), pp. 20160748 - ?

Browse

All of ICR repositoryICR DivisionsIssue dateAuthorsTitlesSubjectsThis collectionIssue dateAuthorsTitlesSubjects

Statistics

Most popular itemsStatistics by countryMost popular authors
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.